Carpal diem! A new, large-scale study finds that medications like Ozempic and Wegovy can seriously reduce knee pain for ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Long acting injection Fluticasone promising in knee osteoarthritis suggests a new study published in the The Lancet ...

Organogenesis (ORGO) announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

Knee osteoarthritis treatments are challenging due to pain and joint structure variability. Lorecivivint (LOR) is an ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

GNSC-001 is designed to offer long-term, sustained inhibition of IL-1 following a single injection into the affected joint; ...